Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Springworks Therapeutics, Inc. (SWTX)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 79,266,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   SpringWorks Therapeutics a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing medicines for underserved patient populations suffering from devastating rare diseases and cancer. Co.'s product candidate, nirogacestat, is an oral, small molecule gamma secretase inhibitor in development as a monotherapy for the treatment of desmoid tumors, a rare and often debilitating and disfiguring soft tissue tumor. Co.'s second product candidate is mirdametinib, an oral, small molecule MEK inhibitor initially in development for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 15,000 49,237 54,055 2,234,484
Total Sell Value $751,550 $2,293,323 $2,428,802 $67,748,752
Total People Sold 1 2 3 5
Total Sell Transactions 1 4 6 12
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 184
  Page 3 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Hambleton Julie Director   –       •      –    2023-03-15 4 S $31.50 $34,841 D/D (1,106) 4,818     -
   Pichl Daniel Chief People Officer   •       –      –    2023-01-26 4 AS $31.00 $26,598 D/D (858) 35,203     -
   Edris Badreddin Chief Operating Officer   •       –      –    2023-01-07 4 D $26.41 $39,166 D/D (1,483) 237,223     -
   Nofi Michael Chief Accounting Officer   •       –      –    2023-01-07 4 D $26.41 $10,802 D/D (409) 16,855     -
   Weinstein Herschel S General Counsel & Secretary   •       –      –    2023-01-07 4 D $26.41 $24,007 D/D (909) 35,830     -
   Pichl Daniel Chief People Officer   •       –      –    2023-01-07 4 D $26.41 $14,420 D/D (546) 36,061     -
   Islam Saqib Chief Executive Officer   •       •      –    2023-01-07 4 D $26.41 $108,202 D/D (4,097) 905,104     -
   Francis Perier I Jr Chief Financial Officer   •       –      –    2023-01-07 4 D $26.41 $28,787 D/D (1,090) 43,463     -
   Smith L. Mary Chief Development Officer   •       –      –    2023-01-07 4 D $26.41 $28,206 D/D (1,068) 212,219     -
   Francis Perier I Jr Chief Financial Officer   •       –      –    2023-01-06 4 D $27.52 $65,332 D/D (2,374) 44,553     -
   Edris Badreddin Chief Operating Officer   •       –      –    2023-01-06 4 D $27.52 $91,532 D/D (3,326) 238,706     -
   Nofi Michael Chief Accounting Officer   •       –      –    2023-01-06 4 D $27.52 $21,548 D/D (783) 17,264     -
   Ashar Bhavesh Chief Commercial Officer   •       –      –    2023-01-06 4 D $27.52 $45,821 D/D (1,665) 45,096     -
   Weinstein Herschel S General Counsel & Secretary   •       –      –    2023-01-06 4 D $27.52 $49,041 D/D (1,782) 36,739     -
   Pichl Daniel Chief People Officer   •       –      –    2023-01-06 4 D $27.52 $47,307 D/D (1,719) 36,607     -
   Cassidy James Chief Medical Officer   •       –      –    2023-01-06 4 D $27.52 $34,758 D/D (1,263) 47,230     -
   Smith L. Mary Chief Development Officer   •       –      –    2023-01-06 4 D $27.52 $67,479 D/D (2,452) 213,287     -
   Islam Saqib Chief Executive Officer   •       •      –    2023-01-06 4 D $27.52 $231,168 D/D (8,400) 909,201     -
   Francis Perier I Jr Chief Financial Officer   •       –      –    2023-01-05 4 A $0.00 $0 D/D 19,425 46,927     -
   Edris Badreddin Chief Operating Officer   •       –      –    2023-01-05 4 A $0.00 $0 D/D 33,994 242,032     -
   Nofi Michael Chief Accounting Officer   •       –      –    2023-01-05 4 A $0.00 $0 D/D 9,713 18,047     -
   Ashar Bhavesh Chief Commercial Officer   •       –      –    2023-01-05 4 A $0.00 $0 D/D 22,663 46,761     -
   Weinstein Herschel S General Counsel & Secretary   •       –      –    2023-01-05 4 A $0.00 $0 D/D 19,425 38,521     -
   Pichl Daniel Chief People Officer   •       –      –    2023-01-05 4 A $0.00 $0 D/D 19,425 38,326     -
   Cassidy James Chief Medical Officer   •       –      –    2023-01-05 4 A $0.00 $0 D/D 22,663 48,493     -

  184 Records found
  1  2  3  4  5  6  7  8   
  Page 3 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed